Cost effectiveness of the MF59-adjuvanted influenza vaccine in France: The "at-risk" adult population

被引：0
|
作者：
Chambers, J. [1 ]
Tollex, K. [2 ]
Piercy, J. [3 ]
Wait, S. [4 ]
机构：
[1] Mapi Values Ltd, Macclesfield, Cheshire, England
[2] Mapi Values, Bollington, Cheshire, England
[3] Adelphi Grp, Bollington, England
[4] SHW Hlth, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65515-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A437 / A437
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of MF59 adjuvanted influenza vaccine in France
    Chambers, J.
    Eijgelshoven, I
    Piercy, J.
    Wait, S.
    VALUE IN HEALTH, 2007, 10 (03) : A163 - A164
  • [2] Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina
    Van Hung Nguyen
    Vizzotti, Carla
    Uruena, Analia
    Giglio, Norberto
    Magneres, Cecilia
    Richmond, Heather
    VACCINE, 2020, 38 (20) : 3682 - 3689
  • [3] The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda, A
    VACCINE, 2001, 19 (17-19) : 2673 - 2680
  • [4] Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato, S
    Granoff, D
    Minutello, M
    Lecchi, G
    Faccini, M
    Agnello, M
    Senatore, F
    Verweij, P
    Fritzell, B
    Podda, A
    VACCINE, 1999, 17 (23-24) : 3094 - 3101
  • [5] Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
    Villa, Marco
    Black, Steven
    Groth, Nicola
    Rothman, Kenneth J.
    Apolone, Giovanni
    Weiss, Noel S.
    Aquino, Ivana
    Boldori, Liana
    Caramaschi, Fausta
    Gattinoni, Antonio
    Malchiodi, Giancarlo
    Crucitti, Antonio
    Della Cioppa, Giovanni
    Scarpini, Elio
    Mavilio, Domenico
    Mannino, Salvatore
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1139 - 1145
  • [6] Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults
    Essink, Brandon
    Fierro, Carlos
    Rosen, Jeffrey
    Figueroa, Amparo L.
    Zhang, Bin
    Verhoeven, Carole
    Edelman, Jonathan
    Smolenov, Igor
    VACCINE, 2020, 38 (02) : 242 - 250
  • [7] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
    Domnich, Alexander
    Arata, Lucia
    Amicizia, Daniela
    Puig-Barbera, Joan
    Gasparini, Roberto
    Panatto, Donatella
    VACCINE, 2017, 35 (04) : 513 - 520
  • [8] Influenza vaccines: Antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population
    Menegon, T
    Baldo, V
    Bonello, C
    Costa, DD
    Di Tommaso, A
    Trivello, R
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (06) : 573 - 576
  • [9] Influenza vaccines: Antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population
    T. Menegon
    V. Baldo
    C. Bonello
    D. Dalla Costa
    A. Di Tommaso
    R. Trivello
    European Journal of Epidemiology, 1999, 15 : 573 - 576
  • [10] MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
    Patel, Sanjay S.
    Bizjajeva, Svetlana
    Heijnen, Esther
    Oberye, Janine
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S18 - S25
12345